Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Med Care. 2014 Mar;52(3):194–201. doi: 10.1097/MLR.0000000000000069

Table 3.

Risk of Poor LDL Control (≥100 mg/dL) by KP.org Refill Function Use, Among Those Non-Adherent to Statins at Baseline (n=3,887)

Fully Adjusted +Mediation by Follow-up Adherence
RR (95% CI) RD (95% CI) RR (95% CI) RD (95% CI)
No refill function use (Ref) -- -- -- --
Occasional use 0.99 (0.86, 1.15) −0.002 (−0.03, 0.03) 1.00 (0.86, 1.15) −0.001 (−0.03, 0.03)
Exclusive use 0.70 (0.56, 0.87)* −0.06 (−0.09, −0.03)* 0.75 (0.60, 0.94)* −0.04 (−0.08, −0.01)*
*

p-value <0.05

Fully adjusted: baseline LDL, age, sex, race, number of medications, and outpatient utilization visits

Mediation model also adjusts for follow-up medication adherence

RD=Risk Difference

RR=Relative Risk